Human HIV Vaccine Trials: Does Antibody-Dependent Enhancement Pose a Genuine Risk?

Antibody-dependent enhancement is a general in vitro property of enveloped viruses. In certain circumstances, antibody-dependent enhancement is a bona fide pathophysiologic mechanism in vivo. There are several examples of virus disease of humans and animals in which incomplete or partial immunity can lead to enhanced infection and/or disease. In some cases, this appears to be attributable to antibody-dependent enhancement. Conversely, there are several examples of viruses for which in vitro antibody-dependent enhancement has been demonstrated, but for which vaccines have been used safely in millions of persons for decades. Finally, antibody-dependent enhancement of HIV is a genuine concern. However, to date there is no direct clinical, experimental, or epidemiological evidence that HIV enhancement can be operative in vivo. Such evidence should be actively sought.

[1]  V. Fulginiti,et al.  Altered Reactivity to Measles Virus: Atypical Measles in Children Previously Immunized With Inactivated Measles Virus Vaccines , 1967 .

[2]  R. Hawkes,et al.  ENHANCEMENT OF THE INFECTIVITY OF ARBOVIRUSES BY SPECIFIC ANTISERA PRODUCED IN DOMESTIC FOWLS. , 1964, The Australian journal of experimental biology and medical science.

[3]  F. Ennis,et al.  Gamma interferon augments Fc gamma receptor-mediated dengue virus infection of human monocytic cells , 1988, Journal of virology.

[4]  F. Scott,et al.  Antibody-mediated enhancement of disease in feline infectious peritonitis: Comparisons with dengue hemorrhagic fever☆ , 1981, Comparative Immunology, Microbiology and Infectious Diseases.

[5]  W. F. Cleary,et al.  Effective protection of monkeys against death from street virus by post-exposure administration of tissue-culture rabies vaccine. , 1971, Bulletin of the World Health Organization.

[6]  D. Porter,et al.  THE PATHOGENESIS OF ALEUTIAN DISEASE OF MINK I. IN VIVO VIRAL REPLICATION AND THE HOST ANTIBODY RESPONSE TO VIRAL ANTIGEN , 1969 .

[7]  L. Vaickus,et al.  Analysis of human peripheral blood mononuclear cells bearing Fc receptors for the three major immunoglobulin isotypes. , 1988, Clinical immunology and immunopathology.

[8]  P. Krause,et al.  Measles-specific lymphocyte reactivity and serum antibody in subjects with different measles histories. , 1980, American journal of diseases of children.

[9]  E. Norrby,et al.  Differences in the appearance of antibodies to structural components of measles virus after immunization with inactivated and live virus. , 1975, The Journal of infectious diseases.

[10]  D. Huso,et al.  Modulation of lentivirus replication by antibodies: Fc portion of immunoglobulin molecule is essential for enhancement of binding, internalization, and neutralization of visna virus in macrophages , 1989, Journal of virology.

[11]  L. Borysiewicz,et al.  Induction of immunoglobulin G Fc receptors by recombinant vaccinia viruses expressing glycoproteins E and I of herpes simplex virus type 1 , 1990, Journal of virology.

[12]  V. Fulginiti,et al.  Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccines. , 1967, JAMA.

[13]  P. Cash,et al.  In vitro enhancement of respiratory syncytial virus infection of U937 cells by human sera. , 1989, The Journal of general virology.

[14]  D. Montefiori,et al.  Antibody-independent, complement-mediated enhancement of HIV-1 infection by mannosidase I and II inhibitors. , 1989, Antiviral research.

[15]  D. Montefiori,et al.  WILL ANTIBODY-DEPENDENT ENHANCEMENT OF HIV-1 INFECTION BE A PROBLEM WITH AIDS VACCINES? , 1988, The Lancet.

[16]  J. Levy,et al.  Serum enhancement of human immunodeficiency virus (HIV) infection correlates with disease in HIV-infected individuals , 1990, Journal of virology.

[17]  A. Helenius,et al.  Virus Entry into Animal Cells , 1989, Advances in Virus Research.

[18]  W. Brandt,et al.  Current Approaches to the Development of Dengue Vaccines and Related Aspects of the Molecular Biology of Flaviviruses , 1988 .

[19]  M. Greaves,et al.  The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus , 1984, Nature.

[20]  J. Unkeless,et al.  Structure and function of human and murine receptors for IgG. , 1988, Annual review of immunology.

[21]  S. Halstead,et al.  Pathogenesis of dengue: challenges to molecular biology. , 1988, Science.

[22]  A. Nisalak,et al.  Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. , 1989, The American journal of tropical medicine and hygiene.

[23]  K. Khalili,et al.  Cell type-specific expression of JC virus early promoter is determined by positive and negative regulation , 1989, Journal of virology.

[24]  P. Yager,et al.  A rapid reproducible test for determining rabies neutralizing antibody. , 1973, Bulletin of the World Health Organization.

[25]  C. Stoddart,et al.  Intrinsic resistance of feline peritoneal macrophages to coronavirus infection correlates with in vivo virulence , 1989, Journal of virology.

[26]  R. Chanock,et al.  An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. , 1969, American journal of epidemiology.

[27]  Z. Galzie.  Structure and function of human and murine receptors for IgG. , 1991, Indian journal of biochemistry & biophysics.

[28]  Henry P. Treffers,et al.  Complement , 1966, The Yale Journal of Biology and Medicine.

[29]  R. M. Hendry,et al.  Respiratory virus infection of peripheral blood monocytes: correlation with ageing of cells and interferon production in vitro. , 1987, The Journal of general virology.

[30]  J. Hoxie,et al.  CD4-independent infection of human neural cells by human immunodeficiency virus type 1 , 1989, Journal of Virology.

[31]  D. Montefiori,et al.  ANTIBODY-DEPENDENT ENHANCEMENT OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INFECTION , 1988, The Lancet.

[32]  J. Groopman,et al.  Infection of nonlymphoid cells by human immunodeficiency virus type 1 or type 2 , 1990, Journal of virology.

[33]  J. S. Porterfield.  Antibody-mediated enhancement of rabies virus , 1981, Nature.

[34]  S. Halstead.  In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. , 1979, The Journal of infectious diseases.

[35]  R. Chanock,et al.  Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. , 1969, American journal of epidemiology.

[36]  J. S. Porterfield.  Antibody-dependent enhancement of viral infectivity. , 1986, Advances in virus research.

[37]  R. Gens,et al.  Severe local reactions to live measles virus vaccine following an immunization program. , 1983, American Journal of Public Health.

[38]  D. Dormont,et al.  ANTIBODY-DEPENDENT ENHANCEMENT OF HIV INFECTION , 1988, The Lancet.

[39]  J. Zeuthen,et al.  Analysis of a highly immunodominant epitope in the human immunodeficiency virus type 1 transmembrane glycoprotein, gp41, defined by a human monoclonal antibody , 1990, Journal of virology.

[40]  E. Walsh,et al.  Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine , 1986, Journal of clinical microbiology.

[41]  M. Blaser,et al.  Identification of a unique IgG Fc binding site in human intestinal epithelium. , 1989, Journal of immunology.

[42]  J. Schlesinger,et al.  Antibody‐mediated infection of macrophages and macrophage‐like cell lines with 17D‐yellow fever virus , 1981, Journal of medical virology.

[43]  HIV susceptibility conferred to human fibroblasts by cytomegalovirus-induced Fc receptor. , 1990, Disease Markers.

[44]  Y. Masuho,et al.  Human monoclonal antibodies to the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein gp41 enhance HIV-1 infection in vitro. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Hoxie,et al.  CD 4-Independent Infection of Human Neural Cells by Human Immunodeficiency Virus Type 1 , 2022 .

[46]  D. S. Adams,et al.  Acute arthritis in caprine arthritis-encephalitis virus challenge exposure of vaccinated or persistently infected goats. , 1986, American journal of veterinary research.

[47]  J. Allan,et al.  Enhancement of SIV infection with soluble receptor molecules. , 1990, Science.

[48]  S. S. Chen,et al.  Phenotypic mixing between human immunodeficiency virus and vesicular stomatitis virus or herpes simplex virus. , 1990, Journal of acquired immune deficiency syndromes.

[49]  F. Chiodi,et al.  Enhancement of Human Immunodeficiency Virus (HIV) Replication in Human Monocytes by Low Titres of Anti‐HIV Antibodies in Vitro , 1989, Scandinavian journal of immunology.

[50]  B. Andral,et al.  A model in mice for the study of the early death phenomenon after vaccination and challenge with rabies virus. , 1980, The Journal of general virology.

[51]  F. Ennis,et al.  FcR-mediated enhancement of HIV-1 infection by antibody. , 1990, AIDS research and human retroviruses.

[52]  R. Gallo,et al.  Expanded HIV-1 cellular tropism by phenotypic mixing with murine endogenous retroviruses. , 1990, Science.

[53]  F. Ennis,et al.  Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. , 1988, Science.

[54]  D. Montefiori,et al.  A human immunodeficiency virus type 1 (HIV-1) infection-enhancing factor in seropositive sera. , 1987, Biochemical and biophysical research communications.

[55]  H. Vennema,et al.  Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization , 1990, Journal of virology.

[56]  Dani P. Bolognesi.  Do antibodies enhance the infection of cells by HIV? , 1989, Nature.

[57]  G. Georgsson,et al.  The effect of post-infection immunization on the severity of experimental visna. , 1981, Journal of comparative pathology.

[58]  D. Montefiori,et al.  Complement-mediated, infection-enhancing antibodies in plasma from vaccinated macaques before and after inoculation with live simian immunodeficiency virus , 1990, Journal of virology.